Kelly K O'Brien1,2,3, Anne-Marie Tynan4, Stephanie A Nixon5,6, Richard H Glazier7,4,8,9,10. 1. Department of Physical Therapy, University of Toronto, 500 University Avenue, Room 160, Toronto, ON, Canada. kelly.obrien@utoronto.ca. 2. Rehabilitation Sciences Institute (RSI), University of Toronto, 500 University Avenue, Room 160, Toronto, ON, Canada. kelly.obrien@utoronto.ca. 3. Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto, Toronto, ON, Canada. kelly.obrien@utoronto.ca. 4. Centre for Research on Inner City Health, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada. 5. Department of Physical Therapy, University of Toronto, 500 University Avenue, Room 160, Toronto, ON, Canada. 6. Rehabilitation Sciences Institute (RSI), University of Toronto, 500 University Avenue, Room 160, Toronto, ON, Canada. 7. Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto, Toronto, ON, Canada. 8. Institute for Clinical Evaluative Sciences, G1 06 2075 Bayview Ave, Toronto, ON, Canada. 9. Department of Family and Community Medicine, St. Michael's Hospital, 30 Bond Street, Toronto, ON, Canada. 10. Department of Family and Community Medicine, University of Toronto, 500 University Avenue, Toronto, ON, Canada.
Abstract
BACKGROUND: People with HIV are living longer with the health-related consequences of HIV, multi-morbidity, and aging. Exercise is a key strategy that may improve or sustain health for people living with HIV. Our aim was to examine the safety and effectiveness of aerobic exercise interventions on immunological, virological, cardiorespiratory, strength, weight, body composition, and psychological outcomes in adults living with HIV. METHODS: We conducted a systematic review using the Cochrane Collaboration protocol. We searched databases up to April 2013. We included randomized controlled trials comparing aerobic exercise with no exercise or another intervention performed at least three times per week for at least four weeks among adults living with HIV. Two reviewers independently determined study eligibility. Data were extracted from studies that met inclusion criteria using standardized forms. We assessed risk of bias using the Cochrane Collaboration's tool for assessing risk of bias. Outcomes were analyzed as continuous and meta-analyses conducted using random effects models with Review Manager (RevMan) computer software. RESULTS: Twenty-four studies met inclusion criteria (n = 936 participants at study completion); the majority of participants were men (73 %) and the majority were taking antiretroviral therapy (19/24 included studies). The exercise intervention included aerobic exercise alone (11 studies) or a combination of aerobic and resistive exercise (13 studies) ranging from 5 to 52 weeks. Fifty-eight meta-analyses were performed. Main results indicated statistically significant improvements in selected outcomes of cardiorespiratory status (maximum oxygen consumption, exercise time), strength (chest press, knee flexion), body composition (lean body mass, percent body fat, leg muscle area), depression symptoms, and quality of life (SF-36 questionnaire) among exercisers compared with non-exercisers. No significant differences in change in CD4 count and viral load were found. CONCLUSIONS: Performing aerobic exercise or a combination of aerobic and resistive exercise at least three times per week for at least five weeks is safe and can lead to improvements in cardiorespiratory fitness, strength, body composition and quality of life for adults with HIV. Aerobic exercise is safe and beneficial for adults living with HIV who are medically stable.
BACKGROUND:People with HIV are living longer with the health-related consequences of HIV, multi-morbidity, and aging. Exercise is a key strategy that may improve or sustain health for people living with HIV. Our aim was to examine the safety and effectiveness of aerobic exercise interventions on immunological, virological, cardiorespiratory, strength, weight, body composition, and psychological outcomes in adults living with HIV. METHODS: We conducted a systematic review using the Cochrane Collaboration protocol. We searched databases up to April 2013. We included randomized controlled trials comparing aerobic exercise with no exercise or another intervention performed at least three times per week for at least four weeks among adults living with HIV. Two reviewers independently determined study eligibility. Data were extracted from studies that met inclusion criteria using standardized forms. We assessed risk of bias using the Cochrane Collaboration's tool for assessing risk of bias. Outcomes were analyzed as continuous and meta-analyses conducted using random effects models with Review Manager (RevMan) computer software. RESULTS: Twenty-four studies met inclusion criteria (n = 936 participants at study completion); the majority of participants were men (73 %) and the majority were taking antiretroviral therapy (19/24 included studies). The exercise intervention included aerobic exercise alone (11 studies) or a combination of aerobic and resistive exercise (13 studies) ranging from 5 to 52 weeks. Fifty-eight meta-analyses were performed. Main results indicated statistically significant improvements in selected outcomes of cardiorespiratory status (maximum oxygen consumption, exercise time), strength (chest press, knee flexion), body composition (lean body mass, percent body fat, leg muscle area), depression symptoms, and quality of life (SF-36 questionnaire) among exercisers compared with non-exercisers. No significant differences in change in CD4 count and viral load were found. CONCLUSIONS: Performing aerobic exercise or a combination of aerobic and resistive exercise at least three times per week for at least five weeks is safe and can lead to improvements in cardiorespiratory fitness, strength, body composition and quality of life for adults with HIV. Aerobic exercise is safe and beneficial for adults living with HIV who are medically stable.
Authors: F Pérez-Moreno; M Cámara-Sánchez; J F Tremblay; V J Riera-Rubio; L Gil-Paisán; A Lucia Journal: Int J Sports Med Date: 2007-06-01 Impact factor: 3.118
Authors: Sara E Dolan; Walter Frontera; Jamie Librizzi; Karin Ljungquist; Sandra Juan; Robert Dorman; Morgan E Cole; Jenna R Kanter; Steven Grinspoon Journal: Arch Intern Med Date: 2006-06-12
Authors: Carol Ewing Garber; Bryan Blissmer; Michael R Deschenes; Barry A Franklin; Michael J Lamonte; I-Min Lee; David C Nieman; David P Swain Journal: Med Sci Sports Exerc Date: 2011-07 Impact factor: 5.411
Authors: Susan D Driscoll; Gary E Meininger; Karin Ljungquist; Colleen Hadigan; Martin Torriani; Anne Klibanski; Walter R Frontera; Steven Grinspoon Journal: J Clin Endocrinol Metab Date: 2004-05 Impact factor: 5.958
Authors: Melanie Rusch; Stephanie Nixon; Arn Schilder; Paula Braitstein; Keith Chan; Robert S Hogg Journal: Health Qual Life Outcomes Date: 2004-09-06 Impact factor: 3.186
Authors: Allison R Webel; Joseph Perazzo; Christopher T Longenecker; Trevor Jenkins; Abdus Sattar; Margaret Rodriguez; Nate Schreiner; Richard A Josephson Journal: J Cardiovasc Nurs Date: 2018 May/Jun Impact factor: 2.083
Authors: Kristine M Erlandson; Samantha MaWhinney; Melissa Wilson; Lilyana Gross; Sean A McCandless; Thomas B Campbell; Wendy M Kohrt; Robert Schwartz; Todd T Brown; Catherine M Jankowski Journal: AIDS Date: 2018-10-23 Impact factor: 4.177
Authors: Monty Montano; Shalender Bhasin; Richard T D'Aquila; Kristine M Erlandson; William J Evans; Nicholas T Funderburg; Amy Justice; Lishomwa C Ndhlovu; Bisola Ojikutu; Marco Pahor; Savita Pahwa; Alice S Ryan; Jennifer Schrack; Michael B Schultz; Paola Sebastiani; David A Sinclair; Julia Tripp; Bruce Walker; Julie A Womack; Raymond Yung; R Keith Reeves Journal: AIDS Res Hum Retroviruses Date: 2019-09-23 Impact factor: 2.205
Authors: Allison R Webel; Shirley M Moore; Chris T Longenecker; Jackson Currie; Christine Horvat Davey; Joseph Perazzo; Abdus Sattar; Richard A Josephson Journal: J Acquir Immune Defic Syndr Date: 2018-05-01 Impact factor: 3.731